[Protective effect of baicalin against LPS-induced intestinal injury]

Qiong Wu1, Hua Ye2, Yu-Zhen Zhu2

  • 1Teaching and Research Room of Pharmacology, Guangdong Medical College, Zhanjiang 524023, China. wqzs2006@163.com

Abstract

Insights

Baicalin significantly reduces intestinal injury and mortality in septicopyemia models. This natural compound protects against endotoxin-lipopolysaccharide (LPS) induced damage by improving gut mucosal integrity.

Area of Science:

  • Pharmacology
  • Toxicology
  • Gastroenterology

Context:

  • Sepsis-induced gut injury is a critical complication.
  • Endotoxin-lipopolysaccharide (LPS) is a key mediator of septic shock.
  • Intestinal mucosal barrier dysfunction contributes to sepsis progression.

Purpose:

  • To evaluate the protective effects of baicalin against LPS-induced intestinal injury.
  • To investigate the anti-oxidative properties of baicalin in the context of septicopyemia.
  • To assess baicalin's impact on colonic and ileal mucosa in a rat model.

Summary:

  • Baicalin administration reduced mortality rates in LPS-treated mice.
  • Significant protection against colonic and ileal mucosal injury was observed with baicalin treatment.
  • Histopathological analysis revealed improved intestinal structure in baicalin-treated groups.
  • While antioxidant markers (T-AOC, T-SOD, GSH-PX) did not significantly increase, baicalin improved mucosal integrity.

Impact:

  • Baicalin demonstrates therapeutic potential for managing sepsis-related gastrointestinal complications.
  • Findings suggest baicalin's protective mechanism involves preserving intestinal mucosal structure and function.
  • Further research into baicalin's specific anti-inflammatory and cytoprotective pathways is warranted.

Related Concept Videos